MedPage Today on MSN
PSMA-PET Cuts Need for Biopsy in Suspected Prostate Cancer
But does it cost too much?
"This technology gives us a powerful tool to detect prostate cancer earlier and more precisely,” said Dr. James Howard.
Tagawa, MD, identified 3 primary clinical scenarios where PSMA PET scans have become the established standard for prostate cancer care. The first application is initial s ...
LOS ANGELES (KABC) -- New technology that's allowing doctors to pinpoint prostate cancer long before it becomes a threat is now widely available. A former firefighter mentioned how this new imaging ...
Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
Surgery patients staged with PSMA-PET appear to have a lower risk of early BCR than those staged with conventional imaging. Early oncologic outcomes after radical prostatectomy (RP) for very high risk ...
A new radioactive diagnostic agent for use in prostate cancer has been approved by the US Food and Drug Administration (FDA). The product, Gallium 68 PSMA-11 (Ga 68 PSMA-11), has been approved for ...
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...
A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.
Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting ...
Watchdog finds failings in prostate cancer treatment in North Wales going back almost a decade.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results